Legionella Pneumonia in Neutropenic Hairy Cell Leukemia: A Case Report

Chukwuemeka A. Umeh^1, , Mohammad A. Yousuf¹ and Hycienth Ahaneku²

¹Department of Internal Medicine, Hemet Valley Medical Center, Hemet, California, USA

²Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston TX, USA

Cite this paper:
Chukwuemeka A. Umeh, Mohammad A. Yousuf and Hycienth Ahaneku. Legionella Pneumonia in Neutropenic Hairy Cell Leukemia: A Case Report. American Journal of Medical Case Reports. 2020; 8(8):250-252. doi: 10.12691/ajmcr-8-8-10

Abstract

Immunocompromised patients, especially those with cell-mediated immune deficiency are susceptible to legionella infection. We report the case of a hairy cell leukemia patient with legionella pneumonia and neutropenic fever. Patient was diagnosed with legionella pneumonia after two weeks of antimicrobial treatment for non-responding pneumonia and neutropenic fever. This case highlights the importance of high suspicion for legionella in immunocompromised pneumonia patients with neutropenic fever and the need for empiric coverage of atypical microbes in treatment of pneumonia in neutropenic immunocompromised patients.

Keywords:
legionella pneumonia neutropenic fever hairy cell leukemia

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Cunha BA, Burillo A, Bouza E. Legionnaires' disease. The Lancet. 2016 Jan 23; 387(10016): 376-85.
[2]	Stout JE, Yu VL. Legionellosis. New England Journal of Medicine. 1997 Sep 4; 337(10): 682-7.
[3]	Burillo A, Pedro-Botet ML, Bouza E. Microbiology and epidemiology of legionnaire's disease. Infectious Disease Clinics. 2017 Mar 1; 31(1): 7-27.
[4]	Grever MR, Abdel-Wahab O, Andritsos LA, Banerji V, Barrientos J, Blachly JS, Call TG, Catovsky D, Dearden C, Demeter J, Else M. Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia. Blood, The Journal of the American Society of Hematology. 2017 Feb 2; 129(5): 553-60.
[5]	Schlossberg D, Bonoan J. Legionella and immunosuppression. In Seminars in respiratory infections 1998 Jun (Vol. 13, No. 2, pp. 128-131).
[6]	Fang GD, Stout JE, Yu VL, Goetz A, Rihs JD, Vickers RM. Community-acquired pneumonia caused by Legionella dumoffii in a patient with hairy cell leukemia. Infection. 1990 Nov 1; 18(6): 383-5.
[7]	Tan MJ, Tan JS, File Jr TM, Hamor RH, Breiman RF. The radiologic manifestations of Legionnaire's disease. Chest. 2000 Feb 1; 117(2): 398-403.
[8]	Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File Jr TM, Musher DM, Niederman MS, Torres A. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clinical infectious diseases. 2007 Mar 1; 44(Supplement_2): S27-72.
[9]	Murdoch D, Chambers ST, Priest P. Treatment and prevention of Legionella infection. Ramirez JA, Bond S, editors. UpToDate [Internet]. Waltham, MA: UpToDate Inc. Available from https://www.uptodate.com (Accessed on March 28, 2020.).